Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Nizar, Mahlaoui"'
Autor:
Siobhan Oisin Burns, Nizar Mahlaoui
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/826d9dbf32534be98997a9a0ebed8ac6
Publikováno v:
Frontiers in Epidemiology, Vol 4 (2024)
Survival analysis (also referred to as time-to-event analysis) is the study of the time elapsed from a starting date to some event of interest. In practice, these analyses can be challenging and, if methodological errors are to be avoided, require th
Externí odkaz:
https://doaj.org/article/fbe26d6115144430b6862ba12198cebb
Autor:
Samya Van Coillie, Johan Prévot, Silvia Sánchez-Ramón, David M. Lowe, Michael Borg, Brigitte Autran, Gesmar Segundo, Antonio Pecoraro, Nicolas Garcelon, Cornelis Boersma, Susana L. Silva, Jose Drabwell, Isabella Quinti, Isabelle Meyts, Adli Ali, Siobhan O. Burns, Martin van Hagen, Martine Pergent, Nizar Mahlaoui
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The International Patient Organisation for Primary Immunodeficiencies (IPOPI) held its second Global Multi-Stakeholders’ Summit, an annual stimulating and forward-thinking meeting uniting experts to anticipate pivotal upcoming challenges and opport
Externí odkaz:
https://doaj.org/article/a360c4410d354f929b13dc536d9cc795
Autor:
Nizar Mahlaoui, Fanny Fouyssac, Françoise Mazingue, Coralie Mallebranche, Malika Barthez-Toullec, Lamia Denti, Kalaivani Ruhier, Marie-Hélène André-Bonnet, Aude Marie-Cardine, Nathalie Aladjidi, Jean-Louis Stephan
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
IntroductionThis study presents the results of a real-life, multicenter, prospective, post-approval safety evaluation of Clairyg® 50 mg/mL, a 5% intravenous immunoglobulin (IVIg) liquid, in 59 children (aged
Externí odkaz:
https://doaj.org/article/d8132084468e477497328dbe00d6d619
Autor:
Susan Tadros, Johan Prévot, Isabelle Meyts, Silvia Sánchez-Ramón, Nahla H. Erwa, Alain Fischer, Guillaume Lefevre, Matthew Hotchko, Peter M. Jaworski, Helen Leavis, Cornelis Boersma, Jose Drabwell, Martin van Hagen, Samya Van Coillie, Martine Pergent, Siobhan O. Burns, Nizar Mahlaoui
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IPOPI held its first Global Multi-Stakeholders’ Summit on 23-24 June 2022 in Cascais, Portugal. This IPOPI initiative was designed to set the stage for a stimulating forward-thinking meeting and brainstorming discussion among stakeholders on the fu
Externí odkaz:
https://doaj.org/article/78d2308fcd78472e913d8c9e512c6c42
Autor:
Leire Solís, Julia Nordin, Johan Prevot, Nizar Mahlaoui, Silvia Sánchez-Ramón, Adli Ali, Elodie Cassignol, John W. Seymour, Martine Pergent
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-8 (2022)
Abstract Background The “Primary Immunodeficiencies (PIDs) principles of care” were published in 2014 as the gold standard for care of patients with PIDs, setting a common goal for stakeholders to ensure that patients with PID have access to appr
Externí odkaz:
https://doaj.org/article/f3a6de04641e49dab40da6624d10181e
Autor:
Chee Mun Chan, Nizar Mahlaoui, Silvia Sánchez−Ramón, Martine Pergent, Leire Solis, Johan Prevot, Adli Ali
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveTo analyze the implementation of the Principles of Care (PoC) in primary immunodeficiencies (PID) in Southeast Asia (SEA) countries - six years after its call of action.MethodologyUsing the newly developed PID Life Index software, the index
Externí odkaz:
https://doaj.org/article/7d601f3b162247f89f9bc337427a7479
Autor:
Maurizio Scarpa, James R. Bonham, Carlo Dionisi-Vici, Johan Prevot, Martine Pergent, Isabelle Meyts, Nizar Mahlaoui, Peter C.J.I. Schielen
Publikováno v:
The Lancet Regional Health. Europe, Vol 13, Iss , Pp 100311- (2022)
Externí odkaz:
https://doaj.org/article/4b105d475b3547b7a2a4b9e8ab85869f
Autor:
Julia Nordin, Leire Solís, Johan Prévot, Nizar Mahlaoui, Helen Chapel, Silvia Sánchez-Ramón, Adli Ali, John W. Seymour, Martine Pergent
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
A global gold standard framework for primary immunodeficiency (PID) care, structured around six principles, was published in 2014. To measure the implementation status of these principles IPOPI developed the PID Life Index in 2020, an interactive too
Externí odkaz:
https://doaj.org/article/aed309fed69f471d8af0e0e399a10b01
Autor:
Hélène Goussault, Hélène Salvator, Emilie Catherinot, Marie-Laure Chabi, Colas Tcherakian, Alexandre Chabrol, Morgane Didier, Elisabeth Rivaud, Alain Fischer, Felipe Suarez, Olivier Hermine, Fanny Lanternier, Olivier Lortholary, Nizar Mahlaoui, Philippe Devillier, Louis-Jean Couderc
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Bronchiectasis is a heterogeneous disease depending on etiology. It represents the most frequent non-infectious pulmonary complication of primary immunodeficiencies (PID). We investigated whether bronchiectasis associated with PID
Externí odkaz:
https://doaj.org/article/5ce727ab87db4242ba3bb83b0f3400e1